The 2nd American missionary infected with Ebola is expected to arrive in the United States for treatment on Tuesday. Nancy Writebol was evacuated from Liberia Monday night by a specially equipped medical jet.
Like Indiana native Dr. Kent Brantly, Writebol will be treated at Emory University Hospital in Atlanta. The plane is scheduled to land at noon at the Dobbins Air Reserve Base. Writebol will immediately be transferred to an isolation unit at Emory.
Both Dr. Brantly and his colleague, Nancy Writebol, were infected with the virus while working as medical missionaries in Western Africa. The two are the first to be treated for Ebola in the US.
Both have been injected with an experimental drug, known only as Z-Mapp, which has never been tested on humans. Doctors say, so far, they are showing signs of improvement.
"What it is, is a cocktail of antibodies which are proteins that the body makes to block the virus," said Dr. Anthony Fauci, the Director for the National Institutes of Health.
Another expert, Dr. Jorge Rodriguez, says the experimental drug cannot be tested on others affected by the deadly virus in Africa.
"We don't know if these patients are naturally getting better or whether the serum is really doing something, so before we give the banner of cure to the serum, a lot more studies and a lot more information needs to be gathered," said Dr. Rodriguez, a Board Certified Internist.
So far, nearly 900 people have died from the Ebola virus and around 1,200 have been infected.